ZIM Laboratories Limited (ZIMLAB.NS)
INR 86.66
(0.79%)
INR 86.66
(0.79%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.67 Billion INR | -7.8% |
| 2022 | 3.98 Billion INR | 21.41% |
| 2021 | 3.28 Billion INR | 12.43% |
| 2020 | 2.91 Billion INR | 11.77% |
| 2019 | 2.61 Billion INR | -19.97% |
| 2018 | 3.26 Billion INR | 22.77% |
| 2017 | 2.65 Billion INR | 15.83% |
| 2016 | 2.29 Billion INR | -13.04% |
| 2015 | 2.63 Billion INR | 0.82% |
| 2014 | 2.61 Billion INR | 15.29% |
| 2013 | 2.27 Billion INR | 22.75% |
| 2012 | 1.85 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 818.24 Million INR | -30.58% |
| 2023 Q1 | 674.42 Million INR | -36.02% |
| 2023 FY | 3.67 Billion INR | -7.8% |
| 2023 Q4 | 1.17 Billion INR | 22.4% |
| 2023 Q3 | 962.92 Million INR | 12.2% |
| 2023 Q2 | 858.26 Million INR | 27.26% |
| 2022 Q1 | 927.45 Million INR | -7.15% |
| 2022 FY | 3.98 Billion INR | 21.41% |
| 2022 Q4 | 1.05 Billion INR | 4.4% |
| 2022 Q3 | 1 Billion INR | 1.58% |
| 2022 Q2 | 994 Million INR | 7.18% |
| 2021 FY | 3.28 Billion INR | 12.43% |
| 2021 Q2 | 774.73 Million INR | 20.73% |
| 2021 Q4 | 998.83 Million INR | 15.18% |
| 2021 Q3 | 867.16 Million INR | 11.93% |
| 2021 Q1 | 641.72 Million INR | 9.6% |
| 2020 FY | 2.91 Billion INR | 11.77% |
| 2020 Q3 | 749.06 Million INR | -14.91% |
| 2020 Q2 | 880.33 Million INR | 24.91% |
| 2020 Q1 | 704.75 Million INR | 33.79% |
| 2020 Q4 | 585.5 Million INR | -21.84% |
| 2019 Q1 | 674.07 Million INR | -21.26% |
| 2019 FY | 2.61 Billion INR | -19.97% |
| 2019 Q4 | 526.75 Million INR | -28.18% |
| 2019 Q3 | 733.45 Million INR | 8.19% |
| 2019 Q2 | 677.9 Million INR | 0.57% |
| 2018 Q4 | 856.05 Million INR | -12.69% |
| 2018 FY | 3.26 Billion INR | 22.77% |
| 2018 Q3 | 980.53 Million INR | 36.8% |
| 2018 Q2 | 716.74 Million INR | 0.87% |
| 2018 Q1 | 710.54 Million INR | 10.05% |
| 2017 Q3 | 750.88 Million INR | 19.52% |
| 2017 Q1 | 634.73 Million INR | 0.0% |
| 2017 Q2 | 628.23 Million INR | -1.02% |
| 2017 Q4 | 645.65 Million INR | -14.01% |
| 2017 FY | 2.65 Billion INR | 15.83% |
| 2016 FY | 2.29 Billion INR | -13.04% |
| 2015 FY | 2.63 Billion INR | 0.82% |
| 2014 FY | 2.61 Billion INR | 15.29% |
| 2013 FY | 2.27 Billion INR | 22.75% |
| 2012 FY | 1.85 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 93.987% |
| Hester Biosciences Limited | 3.04 Billion INR | -20.677% |
| Aarti Drugs Limited | 25.28 Billion INR | 85.465% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | 79.757% |
| Albert David Limited | 3.62 Billion INR | -1.395% |
| Alembic Limited | 1.57 Billion INR | -133.366% |
| Alkem Laboratories Limited | 126.67 Billion INR | 97.099% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -141.049% |
| Bajaj HealthCare Limited | 4.73 Billion INR | 22.369% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -817.982% |
| Brooks Laboratories Limited | 794.86 Million INR | -362.366% |
| Eris Lifesciences Limited | 20.09 Billion INR | 81.708% |
| FDC Limited | 19.42 Billion INR | 81.085% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 83.904% |
| Gufic Biosciences Limited | 8.06 Billion INR | 54.44% |
| Hikal Limited | 17.84 Billion INR | 79.406% |
| Ind-Swift Limited | 5.02 Billion INR | 26.858% |
| Innova Captab Limited | 10.81 Billion INR | 66.012% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | 82.768% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -76.097% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 94.517% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | 36.695% |
| Lupin Limited | 196.56 Billion INR | 98.13% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | -0.044% |
| Medico Remedies Limited | 1.44 Billion INR | -153.599% |
| Morepen Laboratories Limited | 17.01 Billion INR | 78.405% |
| Nectar Lifesciences Limited | 16.84 Billion INR | 78.183% |
| Orchid Pharma Limited | 8.19 Billion INR | 55.146% |
| Procter & Gamble Health Limited | 11.51 Billion INR | 68.077% |
| RPG Life Sciences Limited | 5.82 Billion INR | 36.858% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -138.072% |
| Sigachi Industries Limited | 3.98 Billion INR | 7.88% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | 70.323% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | 65.043% |
| Themis Medicare Limited | 3.81 Billion INR | 3.731% |
| Unichem Laboratories Limited | 16.57 Billion INR | 77.826% |
| Vaishali Pharma Limited | 862.79 Million INR | -325.96% |
| Wanbury Limited | 5.75 Billion INR | 36.156% |
| Windlas Biotech Limited | 6.3 Billion INR | 41.752% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | 71.308% |
| Ipca Laboratories Limited | 77.05 Billion INR | 95.231% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 99.242% |
| Venus Remedies Limited | 5.91 Billion INR | 37.862% |
| Sakar Healthcare Limited | 1.54 Billion INR | -138.388% |
| Aurobindo Pharma Limited | 290.01 Billion INR | 98.733% |
| Divi's Laboratories Limited | 78.45 Billion INR | 95.315% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | 71.632% |
| Mankind Pharma Limited | 103.34 Billion INR | 96.444% |
| Sequent Scientific Limited | 13.69 Billion INR | 73.169% |
| Laurus Labs Limited | 50.01 Billion INR | 92.652% |
| Neuland Laboratories Limited | 15.58 Billion INR | 76.42% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | 89.34% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 96.889% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 98.068% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | 12.752% |
| Wockhardt Limited | 27.89 Billion INR | 86.823% |
| Bal Pharma Limited | 3.39 Billion INR | -8.342% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 98.684% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | 52.286% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -284.27% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | 78.082% |
| Shilpa Medicare Limited | 11.53 Billion INR | 68.128% |
| Valiant Laboratories Limited | 1.82 Billion INR | -101.869% |
| Ajanta Pharma Limited | 42.08 Billion INR | 91.268% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | 7.103% |
| Granules India Limited | 45.06 Billion INR | 91.844% |
| Medicamen Biotech Limited | 1.79 Billion INR | -104.966% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -41.765% |
| Piramal Enterprises Limited | 60.33 Billion INR | 93.909% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 96.535% |
| NATCO Pharma Limited | 40.02 Billion INR | 90.817% |
| Suven Life Sciences Limited | 116.92 Million INR | -3043.078% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -628.889% |
| Strides Pharma Science Limited | 40.51 Billion INR | 90.928% |
| Indoco Remedies Limited | 18.17 Billion INR | 79.777% |
| Alpa Laboratories Limited | 1.08 Billion INR | -237.981% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -252.247% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -386.486% |